The Global Polio Laboratory Network was established
In 1990, the Global Polio Laboratory Network (GPLN) was formally established by the World Health Organization (WHO), national…
A live, oral typhoid vaccine (Ty21a, Vivotif Berna by Swiss Serum Institute) was licensed
On Dec. 15, 1989, the live, oral typhoid vaccine (Ty21a, Vivotif Berna by Swiss Serum Institute) was licensed….
egg and poultry production in Britain Brought to standstill with salmonella infection
In 1989, Deputy Health Minister Edwina Currie announced that most of the egg production in Britain was infected…
Biotechnology | CDC | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine | WHO
The CDC established a World Health Organization (WHO) collaborating center for disaster preparedness
In 1989, the U.S. Centers for Disease Control and Prevention (CDC) established a World Health Organization (WHO) collaborating…
McGill University researcher Dr. Bernard Belleau developed antiviral drug 3TC (Lamivudine), a critical component of Hepatitis B and HIV therapies
In 1989, McGill University researcher Dr. Bernard Belleau developed the antiviral drug 3TC (Lamivudine), which became a critical…
Conjugated Haemophilus influenzae type b vaccine (HibTITER by Wyeth-Lederle) was licensed
On Dec. 21, 1988, the conjugated Haemophilus influenzae type b vaccine (HibTITER by Wyeth-Lederle) was licensed. Prior to…
The first World AIDS Day was held to raise awareness of HIV and AIDS around the world
On Dec. 1, 1988, World AIDS Day is held on December 1 each year and is an opportunity…
The World Health Assembly passed a resolution to eradicate polio by the year 2000
On Mar. 11, 1988, the World Health Assembly (the ministers of health of all member states of the…
ACIP recommended Hib conjugate vaccine to all children at 18 months of age
On Jan. 22, 1988, the Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP) recommended…
Global Polio Eradication Initiative was launched as global burden of polio impacts 350,000 in 125 countries annually
In 1988, the World Health Assembly adopted a resolution for the worldwide eradication of polio, marking the launch…
FDA approved Protein-conjugated Haemophilus influenzae type b vaccine (PRP-D, ProHibit by Connaught)
On Dec. 22, 1987, the protein-conjugated Haemophilus influenzae type b vaccine (PRP-D, ProHibit by Connaught) was licensed.
The Red Cross opened the Holland Laboratory (in Maryland) dedicated to biomedical research
In 1987, the Red Cross opened the Jerome H. Holland Laboratory (in Maryland), which was dedicated to biomedical…
U.S. Congress created the National Vaccine Program
On Nov. 14, 1986, the U.S. Congress created the National Vaccine Program (NVP) to coordinate the vaccine research…
Lorne Tyrrell discovered the first antiviral drug to inhibit hepatitis B virus
In 1986, while teaching a graduate course at the University of Alberta, Dr. Tyrrell found clues that might…
The National Childhood Vaccine Injury Act of 1986 was enacted by Congress
In 1986, the National Childhood Vaccine Injury Act was enacted by Congress. The Department of Health and Human…
Rotary International established its PolioPlus program
In 1985, Rotary International established its PolioPlus program, which held two fundraising events. Rotary has contributed over $500…
Center for Discovery and Innovation in Parasitic Diseases (CDIPD) was founded
In 1985, the CDIPD was founded as an NIH-NIAID-supported Tropical Disease Research Unit (TDRU) at University of California,…
The costs of hepatitis B vaccine and its administration became a covered benefit under Medicare Part B
On Sept. 1, 1984, with the enactment of P.L. 98-369 by the U.S. Congress, coverage under Part B…
Discovery that treatment with human recombinant interferon gamma blocks the growth of T. gondii published
On Feb. 8, 1984, Elmer R. Pfefferkorn published his discovery that treatment of human fibroblasts with human recombinant…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics
The International Centre for Genetic Engineering and Biotechnology located Centres India and Italy
In 1984, the International Centre for Genetic Engineering and Biotechnology (ICGEB), the U.N. Industrial Development Organization (UNIDO) bowed…
Two enhanced pneumococcal polysaccharide vaccines were licensed
On Jun. 30, 1983, the U.S. Food and Drug Administration (FDA) licensed two enhanced pneumococcal polysaccharide vaccines (Pneumovax…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics | Vaccine
The Foundation for the Advancement of Military Medicine was established
in May 1983, President Ronald Reagan signed into law a bill that established the Foundation for the Advancement…
Biotechnology | CDC | Diagnostics | Infectious Disease | Life Science News | Therapeutics | U.S. Congress
The name ‘acquired immune deficiency syndrome,’ or AIDS, was selected for the new HIV disease
On Jul. 27, 1982, a meeting in Washington, DC, attended by federal officials, university researchers, community activists, and…
Artificial Intelligence | Biotechnology | Energy | Infectious Disease | Life Science News | Materials | Medical Device | Nanotechnology | U.S. Congress | Vaccine
The Small Business Innovation Research (SBIR) program was established by U.S. Congress
In 1982, the Small Business Innovation Research (SBIR) program, administered by the U.S. Small Business Administration (SBA), was…
The first hepatitis B viral vaccines, developed by Merck and also by the Pasteur Institute, were licensed Both had independently developed plasma-based hepatitis B viral vaccines
In 1982, the first hepatitis B viral vaccines, developed by Merck and also by the Pasteur Institute, were…
The CDC reported an all-time low of measles cases
In 1982, the U.S. Centers for Disease Control and Prevention (CDC) reported an all-time low of measles cases,…
Quadrivalent groups A, C, Y, and W-135 (Menomune A/C/Y/W-135 by Connaught) meningococcal vaccine was licensed
On Nov. 23, 1981, the U.S. Food and Drug Administration licensed Quadrivalent groups A, C, Y, and W-135…
The costs of pneumococcal vaccine and its administration became a covered benefit under Medicare Part B
On Jul. 1, 1981, as a result of the enactment of Public Law 96-611 passed by the U.S….
Merck began to commercialize Ivermectin as veterinary anti-parasitic drug
In 1981, Merck began commercialize ivermectin as a broad-spectrum veterinary anti-parasitic drug that was originally developed to treat…
First human viral vaccine to prevent cancer (hepatitis B vaccine for liver cancer) was introduced
In 1981, the U.S. Food and Drug Administration (FDA) approved a plasma-derived hepatitis B vaccine for human use….